BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;CHILDREN'S MEDICAL CENTER CORPORATION
发明人:
Anthony Rosenzweig,Vassilios J. Bezzerides
申请号：
US15037195
公开号：
US20160287724A1
申请日:
2014.11.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to the use of a CITED4 polypeptide and/or a microRNA-222 or precursor (e.g., pre-miR-222) or mimic thereof, for treating a cardiovascular disease or pathological condition, such as heart failure, myocardial infarction, and for promoting post-myocardial infarction cardiac remodeling in heart tissue.
